FREE shipping over $120 | Australia-wide

News

Pharmacy and healthcare professionals networking at a busy industry exhibition

Glucology at Pharmacy Connect 2026: Let’s Connect

  Next week, the Glucology will be heading to Pharmacy Connect 2026 in Sydney. We’re excited to be part of one of Australia’s key events for the pharmacy industry. Taking place from 9–11 September 2026...
 Glucochews are now available at TerryWhite Chemmart

Glucochews Are Now Available at TerryWhite Chemmart

Glucochews are now available at TerryWhite Chemmart pharmacies across Australia, giving people another convenient place to find Glucology's fast-acting glucose chews. Available in Orange, Raspberry and Lime, each chew contains 3.8g of glucose in a compact, portable format.

10 lessons we’ve learned from 10 years of diabetes

10 Things We’ve Learned From 10 Years of Glucology

To celebrate 10 years of Glucology, we’re sharing 10 lessons we’ve learned from the diabetes community. From the everyday challenges of managing diabetes to new technology, travelling, finding connection and why practical support can make such a difference.

Dexcom G8 VS G7 size

Dexcom Reveals G8 CGM: A Smaller Sensor and the Future of Diabetes Monitoring

Dexcom has revealed its next-generation continuous glucose monitor, the Dexcom G8, featuring a smaller design, extended 15-day wear time, and innovative adaptive accuracy technology. The company also revealed plans for future ketone and potassium monitoring, offering an early look at how diabetes technology may become more personalised, intelligent, and comprehensive in the years ahead.

Box of FreeStyle Libre 2 Plus

Important NDSS Update: FreeStyle Libre 2 Users to Be Automatically Upgraded to FreeStyle Libre 2 Plus

From 1 July 2026, eligible NDSS users currently accessing FreeStyle Libre 2 sensors will be automatically upgraded to FreeStyle Libre 2 Plus. In this article you will find what the change means, the key differences between the two systems, how the NDSS subsidy works, who is eligible, and answers frequently asked questions about the transition.

Tzield

Australia Approves Tzield: A New Chapter for Type 1 Diabetes Care

Australia has approved Tzield, the first new therapy for type 1 diabetes in over 100 years. The treatment can delay progression to stage 3 T1D and the need for insulin therapy in people aged 8+ with stage 2 type 1 diabetes.

BACK TO TOP